Genflow Biosciences plc (GENF.L) Comparison with companies in other sectors?

Genflow Biosciences plc has a share price of 453.55M. You can analyze Genflow Biosciences plc (GENF.L) competitors across different market sectors through stock heatmaps.

What are GENF.L's NET and operating margins?

Genflow Biosciences plc (GENF.L) operating margin is around 0.00, and net profit margin is approximately 0.00 as of the latest reports.

In what way does GENF.L's earnings per share (EPS) trend reflect its financial momentum?

Genflow Biosciences plc (GENF.L) EPS is -0.01 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for Genflow Biosciences plc is -0.62, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for Genflow Biosciences plc?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Genflow Biosciences plc like P/E which is -1.12, P/B which is 2.52, and PEG which is -1.12. Compare them with sector averages to evaluate if the stock is priced fairly.

Genflow Biosciences plc

GENF.L•LSE

Healthcare

Biotechnology

£0.63

£0.00(0.00%)

Genflow Biosciences plc (GENF.L) Fundamental Analysis: Financial Health, Valuation, and Key Ratios

Dive into Apple Inc.’s fundamentals including valuation ratios, profitability, efficiency metrics, and financial health. Use this data to assess long-term investment quality and compare it with sector benchmarks.

EPS (TTM)

$-0.01

P/E Ratio

-0.62

ROE

-1.05%

Net Margin

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$2.83M

Shares OutstandingTotal number of shares issued

$453.55M

Book Value/ShareNet worth per share

$0.002

Revenue/ShareAnnual revenue per share

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$-0.01

Net MarginNet income as percentage of revenue

Operating MarginOperating income as percentage of revenue

ROEReturn on shareholders' equity

-105.34%

ROAReturn on total assets

-151.98%

ROCEReturn on capital employed

-247.76%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$-0.01

Cash/ShareCash and equivalents per share

$0.002

FCF YieldFree cash flow as percentage of market cap

-58.49%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for GENF.LFinancial Ratios Analysis details for GENF.L are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for GENF.LSector Benchmarking details for GENF.L are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Genflow Biosciences plc Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Genflow Biosciences plc. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Genflow Biosciences plc's unique business strengths and challenges.

Key Financial Metrics for Genflow Biosciences plc

For Genflow Biosciences plc, essential financial indicators include EPS -0.01, PE -0.62, and ROE -1.05. These key ratios reveal insights into Genflow Biosciences plc's profitability, valuation, and operational health. Understanding these metrics enables you to compare Genflow Biosciences plc with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Genflow Biosciences plc

Metrics like Net Margin - and ROA -151.98% shed light on how well Genflow Biosciences plc is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Genflow Biosciences plc can sustain its operations and continue growing in the future.

Valuation and Market Position of Genflow Biosciences plc

Using ratios such as P/B Ratio 2.52 and PEG Ratio -1.12, investors can assess whether Genflow Biosciences plc is appropriately valued based on its financials and growth potential. These figures, combined with Genflow Biosciences plc's market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Genflow Biosciences plc

Financial health indicators, such as Debt/Equity Ratio - and Cash Flow $-0.01, provide a snapshot of Genflow Biosciences plc's ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Genflow Biosciences plc, is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Genflow Biosciences plc

Investing in Genflow Biosciences plc based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Genflow Biosciences plc focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;